A Study Evaluating a Proprietary Amino Acid Mixture (Enterade®) in Patients Receiving High-Dose Melphalan Conditioning Followed by Autologous Stem Cell Transplantation for Multiple Myeloma and Non-Hodgkin Lymphoma
A Study Evaluating a Proprietary Amino Acid Mixture (Enterade®) in Patients Receiving High-Dose Melphalan Conditioning Followed by Autologous Stem Cell Transplantation for Multiple Myeloma and Non-Hodgkin Lymphoma
NCT ID: NCT02919670 Phase: NA Status: COMPLETED Enrollment: 114 Completion: 2020-07
Conditions
Multiple Myeloma, Non-Hodgkin's Lymphoma
Interventions
Enterade, Placebo, Standard Supportive Care
Summary
This research study is evaluating Enterade, a supplement, as a possible treatment for the side effects caused by Stem Cell Transplant.
The following interventions will be involved in this study:
- Enterade plus standard supportive care
- Placebo plus standard supportive care. The placebo will be a mixture of water, electrolytes, and sweetener.
Primary Outcome
Number of Participants With Grade 3 or Higher Diarrhea GI Toxicity